News About: Pharm. Industry
Most firms to slash R&D spending in 2012 business plan
A majority of Korean pharmaceutical companies are now busy finalizing their business plans for the new year, but their 2012 budget plan will place top priority on slashing their research and developing (R&D) spending ...
Pharmaceutical firms offer voluntary retirement
Influenced by the government’s plan to slash the price of about half the drugs on the market by an average of 14 percent from next April, some of Korean drug firms are said to cut the size of their manpower through a ...
Dongkook wins patent for sustained-release leuprorelin preparation
Dongkook Pharmaceutical Co. says it has acquired a Korean patent for sustained-release leuprorelin preparation using a biodegradable polymer.
The patent technology is characterized by releasing in the body leuprore...
HanAll to complete Phase II study for Hanferon in U.S. by next February
HanAll BioPharma plans to complete Phase II clinical trial for its biosimilar product Hanferon (interferon alpha; HL-143) in the U.S. during February 2012, as the drug has been successfully administered to all patient...
Daehwa receives U.S. PTO notice of allowance for oral paclitaxel
Daehwa said Wednesday that its patent application entitled “Solubilizing composition for paclitaxel and its manufacturing method” has received notice of allowance from the U.S. Patent and Trademark Office.
Paclitax...
Government urged not to press local pharmaceutical industry
There are pros and cons over the recent remarks made by the health ministry official Ryu Yang-ji in a local symposium on Tuesday.
Rhu said that the local pharmaceutical industry has seen its sales rise 14 percent o...
Vita 500 sales grow 6% in third quarter
The third-quarter sales of Vita 500 energy drink jumped six percent compared with 60 billion won from a year earlier on retailers’ aggressive expansion and boosted marketing, Kangdong Pharmaceutical said Tuesday.
A...
Pharmaceutical industry likely to undergo transition
The local pharmaceutical industry will likely to undergo a major transformation as the government plans to slash the price of about half the drugs on the market by an average of 14 percent starting next April may resh...
KPMA plans mass-scale rally this month
The Korea Pharmaceutical Manufacturers Association (KPMA) plans to hold a large-scale rally on and about November 20 to step up their protests over the government’s drug price cuts.
It said the rally is aimed at de...
Samjin to export clopidogrel bisulfate technology to Indonesia
Samjin Pharmaceutical said Monday it has signed a contract ro supply an Indonesian company with a technology that helps the manufacture of clopidogrel bisulfate, an antiplatelet agent used to inhibit blood clots in co...
